FDA, CDC, NIH, & WHO Stockpile Vaccines for Global 2024-25 H5N1 Flu Pandemic

The FDA stated that they will provide FULL FDA approval for the H5N1 vaccines if a public health emergency is declared without receiving safety or efficacy data from clinical trials.

October 23, 2024: On October 10, 2024, members of the WHO, FDA, CDC, NIH, as well as U.S. infectious disease pediatricians and vaccinologists, held a 6.5 hour meeting to discuss the current status and further development of vaccines for a 2024-2025 H5N1 global flu pandemic.

Jerry Weir, PhD, of the FDA’s Center for Biologics Evaluation Research (CBER) clearly stated (multiple times) that the FDA will provide full FDA approval for an H5N1 (or other H5 strands) flu vaccine if a public health emergency is declared without receiving safety or efficacy data from clinical trials.

Full FDA approval (vs emergency use authorization) of manufacturer’s biological license applications (BLA) will allow federal and state governments, as well as employers, to mandate the H5N1 vaccines for adults and children alike.

Take a listen to this 2.5 minute video of Jerry Weir and Dr. Paul Offit.